# Hims & Hers

Type: Company (HIMS)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/hims-hers
Canonical HTML page: https://gethealthbrief.com/entity/hims-hers

## Timeline

- **2026-02-24**: Global Market Reaction — Industry analysts note the deal as a major consolidation in the GLP-1 and telehealth sectors.
- **2026-02-23**: Payout Details Emerge — Former CCO Joe Harris confirms a payout exceeding $1 million, highlighting the impact on staff wealth.
- **2026-02-19**: Acquisition Announced — Hims & Hers officially announces the $1.6 billion buyout of Sydney-based Eucalyptus.

## Recent coverage (2 stories)

### FDA Issues Warning to Novo Nordisk Over GLP-1 Adverse Event Reporting
2026-03-12 23:24:58 · Sentiment: Negative · Impact: 7/10 · Sources: 3

The FDA has issued a formal warning letter to Novo Nordisk for failing to properly report serious adverse events, including deaths and strokes, related to its GLP-1 medications. This regulatory escalation coincides with a significant market valuation decline and intensifying competition from compounding pharmacies.
Full story: https://gethealthbrief.com/story/fda-warning-novo-nordisk-glp1-reporting-failures

### Hims & Hers Acquires Eucalyptus for $1.6B in Global Telehealth Consolidation
2026-02-24 04:10:02 · Sentiment: Positive · Impact: 7/10 · Sources: 2

US telehealth leader Hims & Hers has finalized a $1.6 billion acquisition of Australian digital health startup Eucalyptus, marking a major expansion into the Asia-Pacific market. The deal, driven by the explosive growth of GLP-1 weight-loss treatments, creates over 100 employee millionaires and solidifies Hims & Hers' position as a global powerhouse in direct-to-consumer healthcare.
Full story: https://gethealthbrief.com/story/hims-hers-eucalyptus-acquisition-glp1-telehealth

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.